Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about STX17: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
STX17 is a gene implicated in neurodegeneration research. Key relationships include: associated with, interacts with, inhibits. Associated with ALS, Aging, Als. Connected to 545 entities in the SciDEX knowledge graph.
| Gene Symbol | STX17 |
| Full Name | Syntaxin 17 |
| Chromosome | 9q31.3 |
| Protein Type | Structural Protein |
| Target Class | Structural Protein |
| Function | STX17-targeting drugs would enhance or modulate autophagosome-lysosome fusion by facilitating SNARE complex assembly, thereby improving autophagic clearance of misfolded proteins and damaged organe... |
| Mechanism of Action | STX17-targeting drugs would enhance or modulate autophagosome-lysosome fusion by facilitating SNARE complex assembly, thereby improving autophagic clearance of misfolded proteins and damaged organelles. This mechanism is particularly relevant for neurodegenerative diseases characterized by protein aggregation. |
| Druggability | Medium (0.46) |
| Clinical Stage | Phase II |
| Pathways | Apoptosis, Autophagy, Cell Cycle, Lysosomal Degradation, Mitophagy |
| UniProt ID | Q9NYQ6 |
| NCBI Gene ID | 55276 |
| Ensembl ID | ENSG00000143891 |
| OMIM | 612598 |
| GeneCards | STX17 |
| Human Protein Atlas | STX17 |
| Associated Diseases | ALS, Aging, Alzheimer's disease, Cardiac, Ftd |
| Known Drugs/Compounds | donanemab, lecanemab, rapamycin |
| Interactions | ATG5, SQSTM1, NOS3, STING1, GLP1R, SREBF1 |
| SciDEX Target | View Target Profile (8 clinical trials) |
| SciDEX Hypotheses | Autophagosome Maturation Checkpoint Control |
| KG Connections | 1121 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
STX17["STX17"] -->|"associated"| Glioblastoma["Glioblastoma"]
STX17["STX17"] -->|"associated"| Tumor["Tumor"]
STX17["STX17"] -->|"associated"| Parkinson["Parkinson"]
STX17["STX17"] -->|"associated"| Ms["Ms"]
STX17["STX17"] -->|"regulates"| Als["Als"]
STX17["STX17"] -->|"interacts"| Aging["Aging"]
VAMP8["VAMP8"] -->|"associated"| STX17["STX17"]
LAMP2["LAMP2"] -->|"associated"| STX17["STX17"]
GBM["GBM"] -->|"associated"| STX17["STX17"]
LC3["LC3"] -->|"associated"| STX17["STX17"]
style STX17 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Autophagosome-Lysosome Fusion | mediates | process | 0.95 |
| ATG14 | binds | protein | 0.90 |
| ER-Mitochondria Contact Site | associated_with | mechanism | 0.90 |
| Endoplasmic Reticulum Membrane Recruitment | mediates | process | 0.90 |
| Replicative Vacuole Formation | contributes_to | process | 0.89 |
| Autophagosome Formation | involved_in | process | 0.85 |
| Mitophagy | involved_in | process | 0.85 |
| Autophagy | involved_in | process | 0.85 |
| VAMP8 | interacts_with | protein | 0.80 |
| Autophagosome-Lysosome Fusion | involved_in | process | 0.80 |
| ULK1 | co_mentioned_with | gene | 0.80 |
| autophagy pathway | participates_in | pathway | 0.80 |
| ubiquitin-proteasome | participates_in | pathway | 0.80 |
| neural stem cells | activates | cell_type | 0.80 |
| STX17_protein | encodes | protein | 0.80 |
| Autophagy | regulates | pathway | 0.80 |
| Tumor | associated_with | disease | 0.75 |
| autophagosome-lysosome fusion | regulates | process | 0.70 |
| VAMP8 | inhibits | gene | 0.70 |
| TFEB | regulates | gene | 0.70 |
| TP53 | regulates | gene | 0.70 |
| Autophagy | activates | pathway | 0.70 |
| AUTOPHAGY | regulates | gene | 0.70 |
| neural stem cells | regulates | cell_type | 0.70 |
| Glioblastoma | associated_with | disease | 0.65 |
| Parkinson | associated_with | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Aging | interacts_with | disease | 0.65 |
| Als | interacts_with | disease | 0.65 |
| Neurodegeneration | therapeutic_target | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Tumor | regulates | disease | 0.65 |
| Tumor | interacts_with | disease | 0.65 |
| Hepatitis | interacts_with | disease | 0.65 |
| Parkinson | inhibits | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Carcinoma | activates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Aging | regulates | disease | 0.65 |
| Carcinoma | inhibits | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Cardiac | associated_with | disease | 0.65 |
| Obesity | activates | disease | 0.65 |
| Inflammation | inhibits | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| zinc | inhibits | protein | 0.90 |
| h-5e68b4ad | targets_gene | hypothesis | 0.90 |
| Zinc | interacts_with | compound | 0.85 |
| SIDE | phosphorylates | protein | 0.85 |
| Acetylation | modulates | process | 0.85 |
| zinc influx | inhibits | phenotype | 0.80 |
| h-5e68b4ad | targets | hypothesis | 0.80 |
| MTOR | regulates | gene | 0.80 |
| MAP1LC3 | regulates | gene | 0.80 |
| ATG | activates | gene | 0.80 |
| MAP1LC3 | activates | gene | 0.80 |
| ATG | regulates | gene | 0.80 |
| RUBCNL | activates | gene | 0.80 |
| rapamycin | targets | drug | 0.80 |
| VAMP8 | associated_with | gene | 0.70 |
| LC3 | associated_with | gene | 0.70 |
| ULK1 | associated_with | gene | 0.70 |
| SQSTM1 | associated_with | gene | 0.70 |
| P62 | associated_with | gene | 0.70 |
| SNAP29 | associated_with | gene | 0.70 |
| TNF | associated_with | gene | 0.70 |
| LAMP1 | associated_with | gene | 0.70 |
| RB1 | activates | gene | 0.70 |
| GAPDH | regulates | gene | 0.70 |
| RB1 | regulates | gene | 0.70 |
| SIRT1 | regulates | gene | 0.70 |
| RB1CC1 | regulates | gene | 0.70 |
| SNAP29 | implicated_in | gene | 0.70 |
| CANCER | regulates | gene | 0.70 |
| CREB | activates | gene | 0.70 |
| AMPK | regulates | gene | 0.70 |
| CREB | regulates | gene | 0.70 |
| RAS | activates | gene | 0.70 |
| RAS | regulates | gene | 0.70 |
| MTORC1 | activates | gene | 0.70 |
| MTORC1 | regulates | gene | 0.70 |
| LAMP2 | associated_with | gene | 0.60 |
| GBM | associated_with | gene | 0.60 |
| EPG5 | associated_with | gene | 0.60 |
| OPTN | associated_with | gene | 0.60 |
| CALCOCO2 | associated_with | gene | 0.60 |
| HSPA8 | associated_with | gene | 0.60 |
| GABARAP | associated_with | gene | 0.60 |
| RTN3 | associated_with | gene | 0.60 |
| DNM1L | associated_with | gene | 0.60 |
| MTOR | associated_with | gene | 0.60 |
| RAB2A | associated_with | gene | 0.60 |
| VAMP7 | associated_with | gene | 0.60 |
| ATG14 | interacts_with | gene | 0.60 |
| ELAVL2 | therapeutic_target | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Autophagosome Maturation Checkpoint Control | 0.494 | neurodegeneration | Autophagy-lysosome pathway convergence a |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.665
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Systemic Neurodegeneration and Brain Aging: Multi-Omics Disintegration, Proteost [PMID:40868276] | Voicu V, Toader C, Șerban M, Covache-Bus | Biomedicines | 2025 | 1 |
| Acetylation in the regulation of autophagy. [PMID:35435793] | Xu Y, Wan W | Autophagy | 2023 | 1 |
| New insights regarding SNARE proteins in autophagosome-lysosome fusion. [PMID:32924745] | Tian X, Teng J, Chen J | Autophagy | 2021 | 1 |
| Autophagosomes form at ER-mitochondria contact sites. [PMID:23455425] | Hamasaki M, Furuta N, Matsuda A, Nezu A, | Nature | 2013 | 1 |
| SNX16 functions as a nutrient-sensitive regulator of autophagosomal components r [PMID:41593027] | Que H, Rong Y | Autophagy | 2026 | 0 |
| Downhill Running Blocks the Mitophagic Flux and Autophagosome-Lysosome Fusion in [PMID:41630123] | Deng H, Zheng S, Li M, Zhang D, Yang T, | Medicine and science in sports | 2026 | 0 |
| Rapid optogenetic manipulation of autophagy reveals that the nuclear pore comple [PMID:41676542] | Mondal P, Cyril A, Parham L, Mamriev D, | bioRxiv : the preprint server | 2026 | 0 |
| NK cell-derived GZMB (granzyme B) suppresses glioblastoma radioresistance by blo [PMID:41378763] | Yan J, Feng R, Qin Q, Shen G, Tian M, Li | Autophagy | 2026 | 0 |
| Unconventional secretion of PARK7 requires lysosomal delivery via chaperone-medi [PMID:40327696] | ["Dash B", "Urano Y", "Mita Y", "Ashida | Proceedings of the National Ac | 2025 | 0 |
| CD147 promotes NSCLC metastasis by inducing secretory autophagy-dependent exosom [PMID:41413248] | Yang J, Liao C, Liang X, Ke Y, Sun Y, Hu | Cell death and differentiation | 2025 | 0 |
| Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acid [PMID:40533746] | ["Sanadgol N", "Abedi M", "Hashemzaei M" | Journal of nanobiotechnology | 2025 | 0 |
| C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pat [PMID:33632058] | ["Beckers J", "Tharkeshwar A", "Van Damm | Autophagy | 2021 | 0 |
| Automated Software System to Promote Anticoagulation and Reduce Stroke Risk: Clu [PMID:28119433] | ["Holt T", "Dalton A", "Marshall T", "Fa | Stroke | 2017 | 0 |
| Evolutionarily conserved role and physiological relevance of a STX17/Syx17 (synt [PMID:24113031] | ["Heged\u0171s K", "Tak\u00e1ts S", "Kov | Autophagy | 2013 | 0 |
| Eukaryotic stress granules are cleared by autophagy and Cdc48/VCP function. [PMID:23791177] | ["Buchan J", "Kolaitis R", "Taylor J", " | Cell | 2013 | 0 |
| Actinic lichen nitidus. [PMID:25386247] | ["Blalock T", "Kannan S", "Davis L"] | Dermatology reports | 2010 | 0 |